Maximum tolerated dose of a new drug is evaluated in:
A
Phase 1
B
Phase 2
C
Phase 3
D
Phase 4
High-Yield Explanation
Phase 1 clinical trial: Used to evaluate Maximum tolerated dose (MTD) of a new drug. Healthy human volunteers are used. Done for safety and non-toxicity.